Omnic 0,4 (Tamsulosin Hydrochloride)

Tamsulosin Hydrochloride, the active ingredient in Omnic 0,4, is an alpha‑1 adrenergic antagonist presented as a 0.4 mg oral tablet for oral use. It treats lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in adult men. GNH USA supplies Omnic 0,4 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omnic 0,4 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omnic 0,4 contains Tamsulosin Hydrochloride, an alpha‑1 blocker that relaxes smooth muscle in the prostate and bladder neck, improving urinary flow. - Benign prostatic hyperplasia (BPH): Reduces urinary frequency, urgency and weak stream associated with an enlarged prostate. - Lower urinary tract symptoms (LUTS): Improves overall urinary symptom scores in men with BPH‑related LUTS. - Pre‑surgical preparation: May be used before transurethral surgery to reduce intra‑operative bleeding by relaxing prostatic smooth muscle.

Tamsulosin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Nasal congestion - Retrograde ejaculation - Abnormal ejaculation - Orthostatic hypotension

Serious or Rare Side Effects: - Severe hypotension - Syncope - Priapism - Allergic skin reactions - Angio‑angulation - Persistent urinary retention.

When using Omnic 0,4, patients and clinicians should consider several safety measures. - Blood pressure monitoring: Check for orthostatic changes before and after starting therapy. - Cardiovascular history: Review    - Renal   - Hepatic  \n- Drug   - Store at     t

The      ---   t   t  d